Abstract
Background
Overdose of cardiovascular medications is increasingly associated with morbidity and mortality. We present a case of substantial atenolol, chlorthalidone, and lisinopril overdose treated by multiple modalities with an excellent outcome.
Conclusion
Aggressive medical intervention did not provide sufficient hemodynamic stability in this patient with refractory cardiogenic and distributive shock. Impella® percutaneous left ventricular assist device and extracorporeal membrane oxygenation provided support while the effects of the overdose subsided. We present concentrations demonstrating removal of atenolol with continuous venovenous hemodiafiltration. This is the first report of esophagogastroduo denoscopy decontamination of this overdose with a large pill fragment burden.
This is a preview of subscription content, log in via an institution to check access.
References
Kerns W, Ransom M, Tomaszewski C et al (1996) The effects of extracellular ions on β-blocker cardiotoxicity. Toxicol Appl Pharmacol 137:1–7
Love JN, Elshami J (2002) Cardiovascular depression resulting from atenolol intoxication. Eur J Emerg Med 9:111–4
Love JN, Howell JM, Litovitz TL, Klein-Schwartz W (2000) Acute beta blocker overdose: factors associated with development of cardiovascular morbidity. Clin Tox 38:275–81
Salhanick SD, Wax PM (2000) Treatment of atenolol overdose in a patient with renal failure using serial hemodialysis and hemoperfusion and associated echocardiographic findings. Vet Hum Toxicol 42:224–5
Huang SS, Tirona RG, Ross C, Suri RS (2013) Case report: atenolol overdose successfully treated with hemodialysis. Hemodial Int 17:652–5
Pfaender M, Casetti PG, Azzolini M, Baldi ML, Valli A (2008) Successful treatment of a massive atenolol and nifedipine overdose with CVVHDF. Minerva Anestesiol 74:97–100
Isgro F, Kiessling AH, Rehn E, Lang J, Saggau W (2003) Intracardiac left ventricular support in beating heart, multi-vessel revascularization. J Card Surg 18(3):240–4
Jurmann MJ, Siniawski H, Erb M, Drews T, Hetzer R (2004) Initial experience with miniature axial flow ventricular assist devices for postcardiotomy heart failure. Ann Thorac Surg 77(5):1642–7
Garatti A, Colombo T, Russo C, Lanfranconi M, Milazzo F, Catena E et al (2005) Different applications for left ventricular mechanical support with the Impella Recover 100 microaxial blood pump. J Heart Lung Transplant 24(4):481–5
Farhat F, Sassard T, Attof Y, Jegaden O (2008) Abdominal aortic aneurysm surgery with mechanical support using the Impella microaxial blood pump. Interact Cardiovasc Thorac Surg 7(3):524–5
Dixon SR, Henriques JP, Mauri L et al (2009) A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. JACC Cardiovasc Interv 2(2):91–6
Abuissa H, Roshan J, Lim B, Asirvatham SJ (2010) Use of the Impella microaxial blood pump for ablation of hemodynamically unstable ventricular tachycardia. J Cardiovasc Electrophysiol 21(4):458–61
Boudoulas KD, Pederzolli A, Saini U et al (2012) Comparison of Impella and intra-aortic balloon pump in high-risk percutaneous coronary intervention: vascular complications and incidence of bleeding. Acute Card Care 14(4):120–4
Sibbald M, Džavík V (2012) Severe hemolysis associated with use of the Impella LP 2.5 mechanical assist device. Catheter Cardiovasc Interv 80(5):840–4
Manzo-Silberman S, Fichet J, Mathonnet A et al (2013) Percutaneous left ventricular assistance in post cardiac arrest shock: comparison of intra-aortic blood pump and IMPELLA Recover LP2.5. Resuscitation 84(5):609–15
O’Neill WW, Kleiman NS, Moses J et al (2012) A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation 126:1717–27
Seyfarth M, Sibbing D, Bauer I et al (2008) A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 52:1584–8
Wells CD, Luckritz TC, Rady MY et al (2012) Bezoar formation requiring endoscopic removal after intentional overdose of extended-release nifedipine. Pharmacotherapy 26:1802–5
Neuvonen PJ, Olkkola KT (1986) Effect of purgatives on antidotal efficacy of oral activated charcoal. Human and Exp Toxicol 5:255–63
Mahmood I (1997) Prediction of absolute bioavailability for drugs using oral and renal clearance following a single oral dose: a critical review. Biopharm Drug Dispos 18:465–73
Flouvat B, Decourt S, Aubert P, Potaux L, Domart M, Goupil A et al (1980) Pharmacokinetics of atenolol in patients with terminal renal failure and influence of haemodialysis. Br J Clin Pharmac 9:379–385
Kountz D, Goldman A, Mikhail J et al (2012) Chlorthalidone: the forgotten diuretic. Postgram Med 124:60–6
Beermann B (1988) Pharmacokinetics of lisinopril. Am J Med 85:25–30
Kelly JG, Doyle GD, Carmody M et al (1988) Pharmacokinetics of Lisinopril, enalapril and enalaprilat in renal failure: effects of haemodialysis. Br J Clin Pharmac 26:781–6
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Heise, C.W., Beutler, D., Bosak, A. et al. Massive Atenolol, Lisinopril, and Chlorthalidone Overdose Treated with Endoscopic Decontamination, Hemodialysis, Impella Percutaneous Left Ventricular Assist Device, and ECMO. J. Med. Toxicol. 11, 110–114 (2015). https://doi.org/10.1007/s13181-014-0419-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13181-014-0419-y